Commercialization: Page 29

PharmaVoice Team/PharmaVoice

Trending 2018: Treatment to Wellness

Attitudes about treating disease are undergoing a fundamental shift as the life-sciences industry faces pressure to demonstrate value. Increasingly, there is a move from treatment to prevention, diagnostics and cure, which KPMG says is leading to the rise of new competitors. By 2030, practitioner...
By Kim Ribbink • Nov. 20, 2017
PharmaVoice Team/PharmaVoice

SHOWCASE FEATURE: eSolutions: Digital Takes Center Stage

Recent trends suggest that pharma companies will continue to invest in digital solutions and partner with innovative technology companies to inform business and clinical decision-making. Yet according to McKinsey, many pharma executives find it hard to determine which digital initiatives to scale...
By PharmaVoice Team • Nov. 20, 2017
PharmaVoice Team/PharmaVoice

Picture This: Managing the Entire Lifecycle of Clinical Trial Images in a Single Tool

One of the great promises of technology is that it can simplify our lives. The need for it to do so is particularly strong in clinical research, where trials have been growing ever more complex. This is due, in part, to regulators’ increasing requests for the inclusion of imaging analysis when ev...
By Tim Kulbago • Nov. 20, 2017
PharmaVoice Team/PharmaVoice

Digital Solutions That Make Sense to Support Sales Team Initiatives

Personal detailing by pharmaceutical sales representatives to physicians and other healthcare professionals has traditionally been the foremost effective way of brand marketing. Reportedly, pharmaceutical companies’ per capita spend on personal detailing visits exceeds direct-to-consumer marketin...
By Brandie Lifante • Nov. 20, 2017
PharmaVoice Team/PharmaVoice

Red Zone: Healing Patients With Digital Warmth: A Prescription for Life Sciences

Earlier this year, ReD Associates and Cognizant conducted an extensive research that cut across disease areas to understand how patients heal – that is, what happens when people face a health risk or issue and need to manage or overcome it. By participating in people’s everyday lives, we found th...
By Bhaskar Sambasivan • Nov. 20, 2017
PharmaVoice Team/PharmaVoice

Red Zone: safety portal: Increasing Patient Safety While Reducing Cost and Complexity

Although it sounds straightforward, global safety reporting of clinical trial adverse events is complicated, time-consuming and extremely expensive. Despite the substantial investment of time and money, research shows that global safety reporting is not protecting patients as well as it could. Dr...
By Steven Beales • Nov. 20, 2017
PharmaVoice Team/PharmaVoice

Red Zone: Leveraging Behavioral Economics to Guide Healthy Decision-Making

People living with long-term health conditions make many decisions about their health, often on a daily basis, including whether to adhere to prescribed treatments. What insights from the world of psychology can help us create effective programs that guide healthy decision-making around adherence...
By Kate Perry • Nov. 20, 2017
PharmaVoice Team/PharmaVoice

The Launch Pad Preparing for Product Launch

Launching a pharmaceutical product has never been easy, but in years past it was certainly simpler. The days of focusing singularly on high-decile prescribing docs and sending out an army of sales reps are a distant memory. Today’s marketers must establish a value story for physicians, patients, ...
By Robin Robinson • Oct. 1, 2017
PharmaVoice Team/PharmaVoice

What Do Millennials Want?

So much has been written about the Millennials. With the exception of Baby Boomers, Millennials are the most talked about and studied generation. Born roughly between 1981 and 1997 (depending on which survey you look at), this generation, we are told, thinks and behaves differently. Some 80 milli...
By Denise Myshko • Oct. 1, 2017
PharmaVoice Team/PharmaVoice

SHOWCASE FEATURE: Patient Solutions: Responding to the Needs of the Savvy Patient

Responding to the Needs of the Savvy Patient When healthcare IT strategist Leonard Kish referred to patient engagement as the blockbuster drug of the century, he tapped into an important realization: that the patient has to be at the center of everything a pharmaceutical company does. Today’s pat...
By PharmaVoice Team • Oct. 1, 2017
PharmaVoice Team/PharmaVoice

A Roadmap for Patient-Centric Patient Support Programs

Patient-centricity is widely embedded into the mission statements and values of biopharma organizations. It gives purpose and urgency to efforts across research, development, and commercialization. Yet patient-centricity often is vaguely defined — making the goal hard to achieve. Teams striving f...
By Lauren Walrath • Oct. 1, 2017
PharmaVoice Team/PharmaVoice

Precision Medicine Meets Precision Patient Support

In the value-driven healthcare environment, orphan drug manufacturers are becoming increasingly aware that improving adherence requires a new approach to patient understanding and support. Take for example the required lifestyle, nutritional or physical modifications often necessary for patient c...
By Kathi Henson • Oct. 1, 2017
PharmaVoice Team/PharmaVoice

Impact Patient Outcomes Without Talking to the Patient

Patient marketers are used to providing valuable patient services and information directly to patients. But if the goal is to accelerate patient outcomes, the needs of the caregiver should also be addressed. Patient marketers know that caregivers play an important part in patients’ lives, but the...
By Andi Weiss • Oct. 1, 2017
PharmaVoice Team/PharmaVoice

The Connected Consumer

At some point during the far-off days of the Carter administration, Carnegie Mellon expanded its Computer Science department, leaving programmers farther away from the department’s only Coke machine. So rather than trek down a couple of floors only to find an empty vending machine, or worse, a ma...
By Johanna Skilling • Oct. 1, 2017
PharmaVoice Team/PharmaVoice

SHOWCASE FEATURE: Supply Chain: The Supply Chain of the Future

Analysts say reimagining processes to take advantage of advanced connectivity can be a supply chain differentiator in the future. The pharmaceutical supply chain, one of the most complex in any industry silo, is also one of the most inefficient and ill-equipped to cope with products in the pipeli...
By PharmaVoice Team • Oct. 1, 2017
PharmaVoice Team/PharmaVoice

Driving Access and Efficiency with a Direct-to-Physician Sampling Program

For commercial teams at pharmaceutical companies, reaching physicians with product messaging has never been more challenging. In fact, according to 2016 research from AccessMonitor1, only 44% of physicians, were considered accessible to pharmaceutical sales representatives — a decline from 80% in...
By Joel wayment • Oct. 1, 2017
PharmaVoice Team/PharmaVoice

Letter from the Editor

Patients as people The term patient-centricity has been used so frequently — including in the pages of PharmaVOICE — that it has almost begun to lose meaning … almost. Patient empowerment began to erode the traditional power center of medicine — the doctor — with the first direct-to-consumer adve...
By Taren Grom • Sept. 1, 2017
PharmaVoice Team/PharmaVoice

Last Word

Takeda’s Digital Advancements Daniel Gandor, Head of Takeda Digital Accelerator USA, talks about the company’s efforts to assess new opportunities in the digital ecosystem. PV: What is the goal of Takeda Digital Accelerator? Gandor: Takeda is committed to the tireless pursuit of how to better ser...
By Daniel Gandor • Sept. 1, 2017
PharmaVoice Team/PharmaVoice

Patient Engagement: New Strategies for a New Era

Clinical trials and traditional marketing efforts are no longer the only way to reach today’s patient consumer. To succeed in the era of digital and health savvy consumers, the industry needs to enlist a more proactive patient engagement strategy that anticipates and meets the evolving needs and ...
By Robin Robinson • Sept. 1, 2017
PharmaVoice Team/PharmaVoice

The Evolution of the MSL

Gaining access to healthcare providers and key opinion leaders has become a key challenge for pharmaceutical companies. In the past, a pharmaceutical company’s success was often determined by the extent its salesforce could access primary care physicians. While the sales representative is still a...
By Denise Myshko • Sept. 1, 2017
PharmaVoice Team/PharmaVoice

True Advocates: Patient Communities for Rare Diseases

According to Global Genes, the mean length of time from symptom onset to accurate diagnosis for patients with rare diseases is 4.8 years. Late diagnosis delays the appropriate treatment and can lead to irreversible and sometimes debilitating complications or even life-threatening consequences, sa...
By Kim Ribbink • Sept. 1, 2017
PharmaVoice Team/PharmaVoice

Drug-Device Combination Development

Products that combine a drug or biologic with a device, such as drug-eluting stents and drug delivery systems, offer new approaches for treating disease, and these innovative drug-device combinations are expected to have a major impact in the coming years. Researchers predict combination products...
By Denise Myshko • Sept. 1, 2017
PharmaVoice Team/PharmaVoice

SHOWCASE FEATURE: Data Management: Key to Moving the Needle

Experts agree that to manage data for business use, it needs to be standardized and formatted in a consistent manner, but the devil is in the details. More than ever, the healthcare industry is challenged with gathering data from multiple sources and comprehending what the massive data sets mean ...
By PharmaVoice Team • Sept. 1, 2017
PharmaVoice Team/PharmaVoice

Good Data In, Good Answers Out: Essence of Data Management in the Era of Data Explosion

Today we have no shortage of data, and the amount that we will be able to utilize continues to increase. While data management can be overwhelming, successful companies are beginning to utilize and realize its power. With proper protocols, business rules, collaborative capabilities, and specialis...
By Danielle Adler • Sept. 1, 2017
PharmaVoice Team/PharmaVoice

Harnessing Information across the Enterprise: Keys to Near and Long-Term Success

Pharma companies find themselves in a predicament when it comes to managing the volume and variety of client, product and other types of data that is vital to multiple functions across the enterprise. Instead of developing an enterprise-wide information management solution, they’ve allowed one-of...
By Michael Allelunas • Sept. 1, 2017